Related references
Note: Only part of the references are listed.Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays
Arantxa Valdivia et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
M. J. Joyner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa et al.
CELL (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
Gregory J. Walker et al.
VIRUSES-BASEL (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis
Niveditha Devasenapathy et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020
Heli Harvala et al.
EUROSURVEILLANCE (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Wen Shi Lee et al.
NATURE MICROBIOLOGY (2020)
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow et al.
NATURE MICROBIOLOGY (2020)
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Kening Li et al.
NATURE COMMUNICATIONS (2020)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)